GGrantIndex
← Leaderboards

Steven J. Burakoff

Dana-Farber Cancer Institute

$9,993,867
Attributed
$9,993,867
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.6M · FY200519
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$27,223,628 · 10

By mechanism

P30$21,846,376 · 5
R01$2,957,677 · 2
P01$1,906,498 · 2
R21$513,077 · 1

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms

Research focus

Malignant NeoplasmsT LymphocyteProgramsAnticancer ResearchLeadershipLaboratory MouseInstitutesCancer Center Support GrantMeetingsAreaYeast Two Hybrid SystemTissue /Cell CultureStructureResourcesGenetically Modified AnimalsBiological Signal TransductionClinical ResearchApoptosisAwardCancer PatientGrowthCollaborationsSeriesCatchment Area

Grant awards (35)

ADMINISTRATION (Admin Core)$947,894
P30 · FY2019 · CA · contact PI
PLANNING AND EVALUATION (Core-001)$203,363
P30 · FY2019 · CA · contact PI
ADMINISTRATION (Admin Core)$1,047,755
P30 · FY2018 · CA · contact PI
PLANNING AND EVALUATION (Core-001)$224,788
P30 · FY2018 · CA · contact PI
ADMINISTRATION (Admin Core)$1,047,755
P30 · FY2017 · CA · contact PI
PLANNING AND EVALUATION (Core-001)$224,788
P30 · FY2017 · CA · contact PI
The Tisch Cancer Institute - Cancer Center Support Grant$2,373,000
P30 · FY2016 · CA · contact PI
ADMINISTRATION (Admin Core)$1,047,754
P30 · FY2016 · CA · contact PI
PLANNING AND EVALUATION (Core-001)$224,789
P30 · FY2016 · CA · contact PI
The Tisch Cancer Institute - Cancer Center Support Grant$1,695,000
P30 · FY2015 · CA · contact PI
ADMINISTRATION (Admin Core)$693,423
P30 · FY2015 · CA · contact PI
DEVELOPMENTAL FUNDS (Core-002)$200,000
P30 · FY2015 · CA · contact PI
PLANNING AND EVALUATION (Core-001)$148,769
P30 · FY2015 · CA · contact PI
Role of HPK1 T cell mediated anti-tumor immune response$254,250
R21 · FY2009 · AI · contact PI
Role of HPK1 T cell mediated anti-tumor immune response$46,952
R21 · FY2009 · AI · contact PI
Role of HPK1 T cell mediated anti-tumor immune response$211,875
R21 · FY2008 · AI · contact PI
Cancer Center Support Grant$2,639,993
P30 · FY2006 · CA · contact PI
Cancer Center Support Grant$2,574,969
P30 · FY2005 · CA
Cancer Center Support Grant$2,574,958
P30 · FY2004 · CA
RAS--ITS REGULATION AND ROLE IN T CELL ACTIVATION$304,200
R01 · FY2004 · CA
Cancer Center Support Grant$2,501,624
P30 · FY2003 · CA
CD4 AND CD8 IN T CELL DEVELOPMENT AND SIGNALING$394,597
R01 · FY2003 · AI
RAS--ITS REGULATION AND ROLE IN T CELL ACTIVATION$303,825
R01 · FY2003 · CA
CD4 AND CD8 IN T CELL DEVELOPMENT AND SIGNALING$383,862
R01 · FY2002 · AI
RAS--ITS REGULATION AND ROLE IN T CELL ACTIVATION$302,925
R01 · FY2002 · CA
THE EFFECTS OF GVHD ON THYMOCYTE DEVELOPMENT$135,290
P01 · FY2002 · CA
CD4 AND CD8 IN T CELL DEVELOPMENT AND SIGNALING$342,419
R01 · FY2001 · AI
RAS--ITS REGULATION AND ROLE IN T CELL ACTIVATION$195,562
R01 · FY2001 · CA
THE EFFECTS OF GVHD ON THYMOCYTE DEVELOPMENT$135,290
P01 · FY2001 · CA
RAS--ITS REGULATION AND ROLE IN T CELL ACTIVATION$109,031
R01 · FY2001 · CA
CANCER CENTER SUPPORT CORE GRANT$1,475,754
P30 · FY2000 · CA
CELLULAR AND MOLECULAR STUDIES OF BONE MARROW TRANSPLANT$1,394,463
P01 · FY2000 · CA
CD4 AND CD8 IN T CELL DEVELOPMENT AND SIGNALING$334,336
R01 · FY2000 · AI
RAS--ITS REGULATION AND ROLE IN T CELL ACTIVATION$286,920
R01 · FY2000 · CA
THE EFFECTS OF GVHD ON THYMOCYTE DEVELOPMENT$241,455
P01 · FY2000 · CA